Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.24.1.1.u2
Condensed Balance Sheets - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 2,353,346 $ 9,165,179
Marketable securities 7,396,009 4,086,873
Accounts receivable 0 0
Prepaid research and development 207,422 219,817
Prepaid expenses and other current assets 851,057 739,179
Total current assets 10,807,834 14,211,048
Equipment and improvements, net 66,804 73,372
Right-of-use asset 193,460 222,227
Total assets 11,068,098 14,506,647
Current liabilities:    
Accounts payable 1,293,755 646,767
Lease obligation, current 151,159 150,095
Accrued expenses and other current liabilities 2,507,589 2,259,955
Insurance premium financing payable 280,614 381,784
Total current liabilities 4,233,117 3,438,601
Lease obligation, net of current portion 58,330 90,124
Total liabilities 4,291,447 3,528,725
Commitments and contingencies (see Note 13)
Stockholders’ equity:    
Preferred stock, $0.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding at March 31, 2024 and December 31, 2023 0 0
Common stock, $0.001 par value; 100,000,000 shares authorized; 6,476,844 and 6,186,280 shares issued and outstanding at March 31, 2024 and December 31, 2023 6,477 6,186
Additional paid-in capital 78,322,334 77,871,584
Accumulated other comprehensive (loss) income (1,800) 877
Accumulated deficit (71,550,360) (66,900,725)
Total stockholders' equity 6,776,651 10,977,922
Total liabilities and stockholders' equity $ 11,068,098 $ 14,506,647